Home › Funds › ACUTA CAPITAL PARTNERS, LLC › RVMD

ACUTA CAPITAL PARTNERS, LLC position in RVMD

REVOLUTION MEDICINES INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 8,237 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.33% of its reported portfolio and ranking #21 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed RVMD holdings in 11 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)8.24K sh
Reported value held$1.69M
Portfolio Weight1.33%
First reportedQ4 2023
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's RVMD position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in RVMD in Q4 2023 at 160,000 shares (US$4.6M). The position peaked in Q2 2024 at 133,000 shares, worth US$5.2M. Across 11 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 8,237 shares valued at US$1.7M. Notable position changes include a 40% trim in Q1 2025 (shares rose 4% over the following quarter), a 85% trim in Q3 2025 (shares rose 71% over the following quarter), a 210% increase in Q1 2026 (shares rose 93% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 160.00K $4.59M New
Q1 2024 143.78K $4.63M Reduce
Q2 2024 133.00K $5.16M Reduce
Q3 2024 108.00K $4.90M Reduce
Q4 2024 111.70K $4.89M Add
Q1 2025 66.66K $2.36M Reduce
Q2 2025 55.69K $2.05M Reduce
Q3 2025 8.41K $392.79K Reduce
Q4 2025 8.41K $669.94K Hold
Q1 2026 26.07K $2.54M Add
Q3 2026 8.24K $1.69M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 55 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held RVMD?

ACUTA CAPITAL PARTNERS, LLC has disclosed RVMD holdings in 11 of the last 12 reported quarters, going back to Q4 2023.

What is ACUTA CAPITAL PARTNERS, LLC's current position in RVMD?

As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 8.24K shares of RVMD (REVOLUTION MEDICINES INC), valued at $1.69M, representing 1.33% of its reported portfolio and ranking #21.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling RVMD?

In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in RVMD. The position peaked in Q2 2024 at 133.00K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.